Study of FK463 for the Treatment of Invasive Aspergillosis

PHASE2CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

January 29, 1999

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions
Aspergillosis
Interventions
DRUG

FK463

Trial Locations (23)

10

Hopital Saint Louis, Service D'Hematologie/Greffe de Moelle, Paris

8036

Medizinische Univ.-Klinik, Graz

20162

Ospedale Niguarda-Ca Granda, Dept. of Internal Medicine Padiglione Brera, Milan

44093

Hotel Dieu, Service d'Hematologie, Nantes

55101

Uniklinik Mainz, Mainz

75015

Hopital Necker Enfants Malades, Service d'Hematologie, Paris

94010

Hopital Henri Mondor, Service d'Hematologie Clinique, Créteil

A-4010

Krankenhaus Elisabethinen Linz, Linz

D-60590

Johann Wolfgang Goethe Universitat, Medizinische Klinik III, Frankfurt

D-67655

Westpfalz Krankehaus, Kaiserslautern

D-04103

Medizinische Klinik und Poliklinik II, Abt. Hamatologie und Onkologie, Leipzig

D-67063

Klinikum der Stadt, Medizinische Klinik A, Ludwigshafen

D-81366

LMU Munchen, Hamatopoetische Zell - Transplantation, München

E-97070

Universitat Wurzburg, Institut fur Molekulare und Infectionsbiologie, Würzburg

I 16132

Nationale Institute for Cancer Research, Genova

00-957

Institute of Haematology and Blood Transfusion, Warsaw

ES 28041

Hospital Clinic I provencial, Servicio Enfermadades Infecciosas, Barcelona

Hospital Doce de Octubre, Servicio de Microbiologia y Enfermadades Infecciosas, Madrid

ES 28007

Hospital Gregorio Maranon, Servicio de Enfermadades Infecciosas, Madrid

SE141 86

Huddinge University Hospital, Dept. of Transplantation Surgery/Immunology, Huddinge

NW3 2QG

Royal Free Hospital, Dept. of Haematological Oncology, London

M20 4BX

Christie Hospital NHS Trust, Manchester

SM2 5PT

Royal Marsden Hospital, Sutton Surrey

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00036166 - Study of FK463 for the Treatment of Invasive Aspergillosis | Biotech Hunter | Biotech Hunter